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In all metazoan organisms, the diversification of cell
types involves determination of cell fates and subse-
quent execution of specific differentiation programs.
During Drosophila myogenesis, identity genes spe-
cify the fates of foundermyoblasts, fromwhich derive
all individual larval muscles. Here, to understand
how cell fate information residing within founders is
translated during differentiation, we focus on three
identity genes, eve, lb, and slou, and how they con-
trol the size of individual muscles by regulating the
number of fusion events. They achieve this by setting
expression levels of Mp20, Pax, and mspo, three
genes that regulate actin dynamics and cell adhesion
and, as we show here, modulate the fusion process
in a muscle-specific manner. Thus, these data show
how the identity information implemented by tran-
scription factors is translated via target genes into
cell-type-specific programs of differentiation.
INTRODUCTION
Correct diversification of cell types and determination of unique
properties of cells in a tissue is crucial for the harmonious
progression through development and formation of functional
organs. In a broad range of developing tissues and metazoan
organisms, diversification of cell fates is controlled by a set of
transcription factors encoded by cell identity genes (e.g.,
Carmena et al., 1998; Halfon et al., 2000; Dalla Torre di Sangui-
netto et al., 2008). A large number of key transcriptional regula-
tors promoting diversification of cell types have been identified
inDrosophila (Skeath, 1999; Baylies andMichelson, 2001;Olson,
2006); however, our understanding of the gene expression
program that operates downstream of identity genes and leads
to the acquisition of specific cell properties remains very limited.
Particularly well suited for studying diversification of cell
types is the Drosophila embryonic musculature, composed of
a set of morphologically distinct muscles, each of which displays
specific properties, such as shape, size, position, innervation,
and attachment points (Bate, 1990). Each muscle, constituted
of one fiber, arises from a specialized myoblast called muscle
founder cell (FC). Specification of individual FCs is determinedDevelopby a combinatorial code of muscle identity genes (Frasch,
1999) including those that are the focus of this work: ladybird
(lb) (Jagla et al., 1998), S59/slouch (slou) (Knirr et al., 1999),
and even-skipped (eve) (Su et al., 1999). Loss of function or
ectopic expression of identity genes transforms the fate of
FCs, causing an aberrant muscle pattern (e.g., Ruiz-Gomez
et al., 1997; Knirr et al., 1999). However, despite significant
progress in understanding FCs specification, the molecular
mechanisms underlying the progression from FC to a mature
muscle having unique properties remains poorly understood.
To date, only a few large-scale approaches have been used to
identify genes expressed in FCs and differentiating muscle
(Artero et al., 2003; Estrada et al., 2006; Sandmann et al.,
2006; Junion et al., 2007). Among them is our previous work
identifying downstream targets of Lb (Junion et al., 2007). This
revealed that during muscle development lb acts at multiple
levels as it not only contributes to the combinatorial code of tran-
scription factors specifying the FCs but also regulates a large
number of genes involved in setting cell shape, adhesion, and
motility. These data suggest that by regulating a set of targets,
the identity genes could control muscle-type-specific programs
of differentiation.
To test this possibility we decided to focus on one of
the earliest events of muscle differentiation, the regulation of
myoblast fusion which leads to the formation of syncytial myo-
tubes with an appropriate size. Fusion is a reiterative process
that occurs during embryonic stages 12–15 (Beckett and
Baylies, 2007) between FCs and a pool of fusion competent
myoblasts (FCMs). The number of fusion events differs from
muscle to muscle, so that at the end of myogenesis, some
muscles contain only four nuclei whereas others can contain
up to 25 nuclei (Bate, 1990). A large number of genes required
for fusion (Abmayr et al., 2008) have been identified; however,
all of them act in all muscles and the mechanisms regulating
number of fusion events in muscle-type-specific manner remain
unknown.
Given that the individual FCs are specified to generate
a muscle of a particular size, one possibility is that the identity
genes control the fusion counting. Here, to test this hypothesis
we focus on the fusion process in five muscles that require the
identity genes eve, lb, and slou (Jagla et al., 1998; Knirr et al.,
1999; Su et al., 1999). We show that these identity genes are
indeed able to control the number of fusion events. They do
this by regulating the expression of regulators of actin cytoskel-
eton and cell adhesion, Muscle protein 20 (Mp20), Paxillin (Pax),mental Cell 19, 317–328, August 17, 2010 ª2010 Elsevier Inc. 317
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(Junion et al., 2007). Eve, Lb, and Slou induce specific combina-
tions of Mp20, Pax, and mspo levels, which in turn determine
specific programs of fusion. Thus, our data provide direct
evidence for the role of muscle identity genes in fusion counting
and, more generally, illustrate how a combinatorial identity code
is translated into a combinatorial realisator code of identity gene
targets that execute cell-type diversification.
RESULTS
Availability of FCMs Has No Impact on Muscle-Specific
Fusion Counting
Myoblast fusion takes place between two types of cells: the FCs
and the FCMs. Although it was shown that each cell type plays
a crucial role in the fusion process (Ruiz-Gomez et al., 2000;
Beckett and Baylies, 2007; Kocherlakota et al., 2008), the role
of each cell type in the control of the number of fusion events
in a muscle-type-specific manner is unknown. Two distinct
models can be proposed to explain how muscle-specific fusion
counting is regulated: (1) FCs and a predefined number of FCMs
are specified locally to determine the size of resulting muscles;
or, (2) only FCs control the number of fusion events whereas
FCMs are not limiting. To analyze themuscle-type-specific regu-
lation of the fusion, we focused our analyses on five muscles:
DA1, SBM, DT1, VA2, and VT1. Following fusion, the new nuclei
provided by the FCMs turn on the identity genes expressed in the
original FC, and therefore we can use antibodies detecting Eve,
Lb, and Slou to count nuclei in DA1, SBM and DT1, VA2, VT1
muscles, respectively.
First, to test if FCMnumber is limiting during fusion processwe
overexpressed the attractant protein Dumbfounded (Duf) (Ruiz-
Gomez et al., 2000) in all FCs using duf-Gal4. This led to an
increased number of nuclei in all muscles analyzed (Figures 1A
and S1, available online; Table S1, available online) suggesting
that FCMs number is a nonlimiting factor during myoblast fusion.
Second, to further investigate whether FCMs could influence
number of fusion events, we manipulated two adjacent muscles,
SBM and VA2 (Figures 1A and 1B). We first sought to reduce the
number of free FCMs around SBM by increasing the number of
VA2 fusion events. This was achieved by overexpressing Duf in
the VA2 FC (slou-Gal4; UAS-duf) (Figure S1; Table S1). Even
though this should reduce the number of nearby FCMs, there
was no change in SBM nuclei number (Figure 1A). Then we per-
formed the reciprocal experiment, increasing FCMs around
SBM, by inducing apoptosis of the VA2 FC (slou-Gal4; UAS-
rpr). This also did not change the nuclei number in SBM. Simi-
larly, VT1, VA2 and SBM were not affected when we destroyed
or increased the size of VL1 (Figure S1; Table S1). Thus, even
if we cannot exclude some compensatory proliferation of FCMs
(Beckett and Baylies, 2007), the induced changes of FCM
number did not influence fusion counting by adjacent muscles,
favoring the secondmodel where the identity information carried
within FCs specifies how many FCMs fuse with each FC.
Fusion Counting Is Regulated by the Identity Genes
in a Muscle-Specific Manner
Identity genes have been shown to be required for FC specifica-
tion; however, their capacity to regulate the number of fusion318 Developmental Cell 19, 317–328, August 17, 2010 ª2010 Elsevieevents has never been analyzed. Each muscle whose formation
depends on specific identity gene contained a consistent
number of nuclei: eve/DA1 has 11 nuclei; lb/SBM 7; and the
slou-dependent DT1, VA2, and VT1 muscles contain, respec-
tively, 8, 9, and 4 nuclei (Figure 1M; Table S1). To investigate
whether Eve, Lb, and Slou activity specifies the number of fusion
events, we have modified their expression using a gain-of-func-
tion approach with duf-Gal4, expressed in all FCs after their
specification, and two FC-specific drivers, slou-Gal4 and eme-
Gal4 (Figures 1C–1M and S1; Table S1). The overexpression of
identity genes in the FCs that normally express these genes
(eve/DA1, lb/SBM and slou/VT1) did not alter the nuclei number
in the resultant muscles (Figure 1M). This demonstrates that the
level of identity gene expression in a muscle in which it is nor-
mally acting does not influence fusion counting. However,
ectopic expression of eve modified counting in DT1 and VA2,
driving them toward the DA1 number (Figure 1M). In this case,
the ectopically expressed eve represses endogenous slou
expression (Figure 1F). In a similar manner, misexpression of lb
leads to repression of eve and slou and the execution of an
SBM-like lb-program of fusion, resulting in formation of DA1,
DT1, and VA2 having seven nuclei (Figures 1H, 1I, and 1M).
Finally, misexpression of slou in the SBM represses endogenous
lb expression and reduces nuclei number to four, similar to VT1
(Figures 1L and 1M). Because different fusion programs are
induced, by ectopic expression of lb versus slou in DA1, even
though both repress eve, our data rule out an indirect effect of
repression.
Altogether, these data demonstrate that identity genes control
muscle size by specifying the number of fusion events: Eve
specifies recruitment of about 10 nuclei, Lb 6 nuclei, and Slou
appears as a key determinant of fusion program involving 3
fusion events (VT1 muscle). However, other muscles expressing
slou have a different nuclei number (VA2 and DT1) (Figure 1M),
leading us to hypothesize that other identity genes coexpressed
with slou contribute to fusion counting in these muscles. Thus,
these data demonstrate that identity genes are sufficient to
specify muscle size by regulating fusion counting.
Identification of Identity Genes Targets Potentially
Involved in Fusion Counting
To understand how identity genes exert their function to control
the number of fusion events, we sought to identify target genes
that may have a role in fusion counting (Figure 2). First, by
screening the BDGP in situ database (www.fruitfly.org/cgi-bin/
ex/insitu.pl), we identified 31 candidates with an expression
pattern restricted to muscle subset consistent with a potential
regulation by identity genes. Among them, we selected candi-
dates with GO annotations suggesting an involvement in cell
adhesion or cytoskeletal regulation, which could have a role in
myoblast fusion, resulting in nine genes (Table S2). Finally, three
of these genes are also Lb targets (Junion et al., 2007): Muscle
Protein 20 (Mp20), Paxillin (Pax), and m-spondin (mspo).
Mp20, Pax, andmspo Display Muscle-Type-Specific
Expression Levels
To characterize in detail Mp20, Pax, and mspo expression
patterns during myogenesis, we used fluorescent in situ hybrid-
izations combined with antibody staining for general andr Inc.
Figure 1. FCs, but Not FCMs, Control Muscle-Type-Specific Fusion Programs
(A) Number of nuclei in SBM and VA2 in WT, duf-Gal4;UAS-duf, slou-Gal4;UAS-duf, and slou-Gal4;UAS-rpr stage 15 embryos stained for Tm2 and Slou or for
b3-Tub and Lb. The histogram (and all following histograms) show the mean number of nuclei and error bars show standard deviation from the mean. Asterisks
show the significance of variation compared to the WT. Growing number of asterisks (1, 2, 3 asterisks) symbolizes the increased significance of variation. The
values used to plot the graphs are shown in Table S1. All driver controls are presented in Figure S1 and Table S1.
(B) Schematic representation of fusion control in SBM and VA2. (Ba) In WT condition the SBM has seven nuclei and the VA2 nine nuclei. (Bb) Pan-muscular duf
overexpression leads to an increase in nuclei number in both muscles. (Bc) Local reduction of FCM number by increasing number of fusion events in the VA2 or
(Bd) local increase of free FCMs by inducing apoptosis in VA2, do not modify the SBM fusion program.
(C) Schematic representation of Eve, Lbe, and Slou expression patterns.
(D–M)Modified fusion programs in embryoswith ectopic expression of eve, lbe, and slou. (D–L) Stage 15 embryos are stained for b3-Tub or Tm2 (green) to label all
muscles and for Eve (D–F, H, and K), Lb (G–I, E, and L), or Slou (J–L, F, and I) to reveal myoblast nuclei in a subset of muscles. WT (D, G, and J) and duf-Gal4;UAS-
eve (E and F), duf-Gal4;UAS-lbe (H and I), duf-Gal4;UAS-slou (K and L) embryos are shown, dorsal is up and anterior is left. Scale bar corresponds to 50 mm.
In mutant contexts, ectopic expression of Eve, Lbe, and Slou is in red and endogenous expression in blue. (M) Number of nuclei in DA1, SBM, DT1, VA2, and
VT1 muscles in wild-type stage 15 embryos and in embryos with duf-Gal4-driven expression of eve, lbe, and slou (see Table S1).
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Figure 2. Selection of Candidate Genes for
Muscle-Specific Regulation of Fusion
Process
To select candidates, we compared two pools of
genes: (1) according to BDGP in situ database,
554 genes are expressed in larval/embryonic
muscle system; among them, 31 show a potential
muscle-specific expression (Table S2) and 9 fit
into GO category ‘‘cell adhesion’’ or ‘‘cytoskeleton
dynamics.’’ (2) The second pool of 141 genes
corresponds to a subset of lb target genes (Junion
et al., 2007) belonging to the category ‘‘cell adhe-
sion/cell motility.’’ Comparison between these two
screens allows us to identify three candidates.
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expressed in a muscle-type-specific manner but also in other
tissues (Figures 3 and S2). Their expression starts at stage 13
and transcripts can be detected in muscles throughout the
muscle fusion period, until stage 15 (Figures 3 and S2). Colabel-
ing with duf-LacZ showed thatMp20, Pax, andmspo are detect-
able in muscles growing by fusion, but not in unfused FCMs
(Figures 3D, 3I, and 3N). These three candidates showed
different levels of expression in our muscles of interest (DA1,
DT1, SBM, VA2, and VT1). Mp20 is expressed at a high level in
VA2 and DT1, at a median level in SBM, at low levels in DA1,
and is not detectable in VT1 (Figures 3A–3C0). Pax is expressed
at a high level in VA2, at amedian level in DT1, and at low levels in
SBM, DA1, and VT1 (Figures 3F–3H0). Finally, mspo transcripts
accumulate at a high level in the DT1, at a median level in VA2,
a low level in DA1 and VT1, and are not detectable in SBM
(Figures 3K–3M0).
To summarize these data, we have employed a color-intensity
code representing the expression levels (high, median, and low)
for each candidate gene (Figures 3E, 3J, and 3O). This analysis
shows that each of the muscles we are focusing on has a unique
signature provided by differing expression levels of the three
candidates.
Expression Level of Mp20, Pax, andmspo Is Regulated
by Identity Genes
Differential muscle-specific expression ofMp20, Pax, andmspo
and the fact they were identified as Lb targets (Junion et al.,
2007) strongly suggest that identity genes regulate their tran-
scription. To confirm this, we induced ectopic expression of
eve, lb, and slou with the panFC duf-Gal4 driver and checked
whether they alter expression patterns of Mp20, Pax, and
mspo. PanFC eve induced a low expression level of the three
candidates in all muscles (Figures 4B, 4F, 4J, and S3) similar to
that normally found in the eve+ muscle DA1. Similarly, panFC
lb and slou induce at ectopic positions the combination of
expression levels ofMp20,Pax, andmspo observed respectively
in lb+ SBM (Figures 4C, 4G, 4K, and S3) and in the slou+ VT1
muscle (Figures 4D, 4H, 4L, and S3). The ectopic slou can also
alter Mp20, Pax, and mspo expression levels in a different
manner that resembles the combinations found in other slou+
muscles, VA2 and DT1. Taken together, our data show that not320 Developmental Cell 19, 317–328, August 17, 2010 ª2010 Elsevieonly lb, but also eve and slou, control the muscle-specific
expression levels of Mp20, Pax, and mspo and are required for
setting the signature patterns of their expression in different
muscles (Figure 4M).
Differential Expression Levels of Mp20, Pax, andmspo
Regulate Fusion Counting in a Muscle-Specific Manner
To test the function of Mp20, Pax, and mspo, we used muscle-
specific knockdown via RNAi (Mp20, Pax) or if available (mspo),
specific null mutation. Furthermore, we generated a molecular
null allele, PaxD1 that deletes almost all of the Pax coding region,
the downstream gene CG31798, and one of two CG17544
transcripts (Figure 5A). Animals homozygous for this mutation
died as pupae, but survived when rescued by a transgene
construct encoding a GFP-tagged version of the Pax gene,
showing that the lethality is caused by the absence of Pax
(Figure S4).
As fusion defects are manifested by the presence of unfused
myoblasts, we first analyzed late-stage embryos lacking Mp20,
Pax, and mspo function. An increased number of unfused cells
was detected with anti-b3-Tub and with anti-MHC stainings in
Mp20 RNAi, Mp20 Df(2R)Exel7124 deficiency and Pax RNAi
and Pax null mutant embryos (Figures 5 and S4) but not in homo-
zygous mspo mutants (Figure 5), suggesting that at least Mp20
and Pax are involved in fusion.
To check whether there is a link between differential expres-
sion of Mp20, Pax, and mspo in muscles and their function in
myoblast fusion we analyzed nuclei number in our muscles of
interest (Figure 6A; Table S3). RNAi knockdown of Mp20
decreased nuclei number by about 2 in muscles DT1 and VA2
that expressMp20 at high levels, while a lower decrease is found
in SBM, which has median Mp20 levels, and there was no
change in muscles with low or absent Mp20, DA1 and VT1. In
a similar manner, Pax RNAi attenuation or the Pax mutation
caused loss of nuclei from muscles expressing a high or median
Pax levels, VA2 and DT1, and no change in DA1, SBM, or VT1
muscles with low Pax. Importantly, rescue experiments of
PaxD1 deficiency showed that Pax-GFP restored the normal
fusion program in affected muscles, whereas the rescue with
a genomic fragment encompassing the PDLP isoform, a trun-
cated form of Pax encoded by the same genomic locus (Yagi
et al., 2001), did not (Figure S5; Table S3). In contrast to Mp20r Inc.
Figure 3. Mp20, Pax, and mspo Display Muscle-Type-Specific Expression Levels
Expression patterns ofMp20 (A–E), Pax (F–J), andmspo (K–O). (A–C0, F–H0, and K–M0) In situ hybridization to revealMp20, Pax, ormspo transcripts (red) coupled
to b3-Tub (green) and muscle-specific staining (blue) for Eve in the DA1 (A, F, and K), for Lbe in the SBM (B, G, and L) in WT embryos, or for LacZ (C, H, and M) in
slou-Gal4;UAS-LacZ context to visualize DT1, LO1, VA2, and VT1muscles. Lateral views of three abdominal segments from stage 15 embryos are shown. (A0–C0),
(F0–H0), and (K0–M0) correspond to the red channel only. (D, I, and N)Mp20, Pax, andmspo expression (in red) in stage 14 duf-LacZ embryos. Growingmuscles are
visualized with b3-Tub (green) and LacZ (blue) staining. During fusion process,Mp20, Pax, andmspo are expressed only in growing muscles and not in unfused
FCMs (white arrows). (E, J, and O) Schematic representation ofMp20 (E), Pax (J), and mspo (O) expression levels. High, median, and low expression levels are
represented by the color intensity.
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was observed in only one muscle (DA1), with relatively low
mspo expression. The finding thatmspo acts as a negative regu-
lator of myoblast fusion is consistent with the lack of unfused
cells inmspomutants (Figure 5D). Altogether, the loss of functionDevelopanalyses show that the muscle-specific levels ofMp20, Pax, and
mspo plays instructive roles in setting the number of fusion
events (Figure 6B).
To further investigate the role of differential expression of
Mp20, Pax, and mspo during myoblast fusion, we tested themental Cell 19, 317–328, August 17, 2010 ª2010 Elsevier Inc. 321
Figure 4. Identity Genes Regulate Mp20, Pax, and mspo Expression Levels
Mp20 (A–D), Pax (E–H), andmspo (I–L) expression patterns inWT (A, E, and I), duf-Gal4;UAS-eve (B, F, and J), duf-Gal4;UAS-lbe (C, G, and K) and duf-Gal4;UAS-
slou (D, H, and L). For each condition, three abdominal segments of stage 15 embryos are shown. Mp20, Pax, or mspo transcripts (red) are revealed by in situ
hybridization coupled to staining for b3-Tub (green). (A0–L0) show the red channel only. Complementary dorsal views are presented in Figure S3. (M) Schematic
representation of identity genes dependent regulation ofMp20, Pax, andmspo expressions and corresponding fusion programmes in DA1, SBM, DT1, VA2, and
VT1muscles. InWT embryos, Eve, Lbe, and Slou induce a specific expression level ofMp20,Pax, andmspo leading to the execution of a specific fusion program.
Ectopic Eve, Lbe, and Slou modulate target’s expression level and leads to the induction of a new fusion programmimicking that induced by a given identity gene
in WT condition.
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press Mp20, Pax, and mspo in DA1 and slou-Gal4 for overex-
pression in DT1, VA2, and VT1 (Figures 6C–6I and S5; Table
S3). Mp20 overexpression increased nuclei number in DA1 but322 Developmental Cell 19, 317–328, August 17, 2010 ª2010 Elsevienot others (Figures 6C, 6E, and S5). The inability of Mp20 over-
expression to increase nuclei numbers in DT1 and VA2 could
be due to a saturation effect due to their high endogenous
Mp20 levels. Similarly, Pax overexpression increased nucleir Inc.
Figure 5. Loss of Mp20 or Pax Functions
Leads to Discrete Fusion Defects
(A) Diagram of the Pax locus, showing the four
Pax transcripts and the short Pax-derived LIM
only protein (PDLP). Two P-element insertions,
EY00742 and EP12861, were used to generate
deletions of the locus. Rescue constructs encom-
passing the Pax locus, PDLP only, or the down-
stream genes were generated. Red arrows indi-
cate the position of the primers used to screen
the candidate deletions. Green arrows represent
the primers used to differentiate the WT allele
versus the rescued Pax allele. (B) WT and (C–G)
loss of function contexts for Mp20, Pax, and
mspo. Lateral views of stage 15 embryos stained
for b3-Tub (green) and Lbe (blue) are shown.
Arrows indicate unfused FCMs. Compared with
the WT (A), an increased number of unfused cells
is present in 24B-Gal4; UAS-RNAi Mp20 (C),
24B-Gal4; UAS-RNAi Pax (E), and PaxD1 (F)
embryos. In mspo mutant embryos (D) and in
PaxD1; Pax-GFP rescue context (G) the number
of unfused cells is similar to that in the WT.
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enous Pax level, was not affected (Figures 6C, 6F, and S5).
In contrast, mspo overexpression decreased nuclei number,
notably in DA1 (Figures 6C, 6G, and S5). Altogether these data
show that altering the expression level of Mp20, Pax, and
mspo results in a proportional modulation of the number of fusion
events.
Finally, we asked how Mp20, Pax, and mspo act together
during modulation of myoblast fusion. First, we ruled out the
possibility that Mp20, Pax, and mspo are interdependent by
analyzing their expression in null mutants for each of them
(Figure S5). Then, we performed double loss- and gain-of-func-
tion experiments. The double RNAi against Mp20 and Pax
induced a strong decrease in nuclei number in DT1 and VA2,
two muscles affected by single RNAi knockdowns (Figure 6A).
In contrast, SBM, in which Pax seems not to be functional, is
affected at the same level in double Pax/Mp20 and in single
Mp20 RNAi contexts (Figure 6A). To test effects of combinatorial
overexpression, we analyzed DA1, whose fusion program is
affected by overexpression of each candidate. The double
Mp20/Pax gain of function induces a strong increase in nuclei
number, much higher than single gain of function of Mp20 or
Pax (Figures 6C and 6H; compare to Figures 6E and 6F), whereas
overexpression of Mp20 and mspo or Pax and mspo restored
a wild-type DA1 nuclei number (Figures 6C and 6I; compare
to Figures 6D, 6E, and 6G). Thus, Mp20, Pax, and mspo have
independent and additive functions in modulation of fusion
programs and contribute to the acquisition of specific properties
of muscles.Developmental Cell 19, 317–328Identity Genes and Their Targets
Regulate Muscle-Specific Number
of Fusion Events by Modulating
Fusion Rate
In order to better understand how the
muscle-specific fusion counting takes
place, we have analyzed the kinetics offusion in DA1, SBM, VA2, and VT1 muscles in wild-type context
by counting number of nuclei at five time points: at embryonic
stage 12, 13, 14, early 15, and late 15. As previously reported
by Beckett and Baylies (2007), the majority of fusion events
occur in all muscles between stage 13 and 15. Our data
(Figure 6J; Table S4) show that, at stage 13, each of four
analyzed muscle precursors contain about two nuclei and
that starting from this point each muscle displays specific
rate of fusion, which is linear between stage 13 and 15. The
fusion rate is low in VT1 and progressively higher in SBM,
VA2, and DA1, suggesting that during the second phase of
fusion the rate is proportional to the final size of the muscle.
Importantly, an ectopic expression of Lb in the DA1 is sufficient
to change the DA1 fusion rate to a SBM-like one showing
that the kinetics of fusion is regulated by the identity genes
(Figure 6J). To determine whether the identity gene targets
also modulate fusion process by accelerating or slowing down
its rate, we analyzed effects of attenuation or overexpression
of Mp20, Pax, and mspo on kinetics of fusion. The attenuation
of Mp20 and Pax leads to a reduced fusion rate measured in
VA2 (Figure 6K), whereas their overexpression results in accel-
erated fusion in DA1 compared to the wild-type (Figure 6L).
In contrast, the overexpression of mspo, acting as a negative
regulator of fusion, slows the fusion rate down (Figure 6L). Alto-
gether the analyses of kinetics of fusion provide an insights
into mechanistic understanding of muscle-type-specific regula-
tion of fusion process revealing that the identity genes and
their targets regulate the number of fusion events by setting
fusion rate., August 17, 2010 ª2010 Elsevier Inc. 323
Figure 6. Mp20, Pax, and mspo Modulate Fusion Process in a Muscle-Type-Specific Manner and According to Their Expression Level
(A) Number of nuclei present in DA1, SBM, DT1, VA2, and VT1 muscles at stage 15 embryos analyzed in WT, 24B-Gal4; UAS-RNAiMp20, 24B-Gal4; UAS-RNAi
Pax,PaxD1,mspoc26 and 24B-Gal4; UAS-RNAiPax; UAS-RNAiMp20. To determine the number of nuclei, embryoswere double-stained for Eve (DA1), Lbe (SBM),
or Slou (DT1, VA2, and VT1) and for b3-Tub or Tm2. Bar graphs show themean number of nuclei and asterisks indicate the significance of variation comparedwith
the WT. The mean values used to plot the graphs are shown in Table S3.
(B) Summary of Mp20, Pax, and mspo functions correlated to their expression levels.
(C–I) Effect ofMp20,Pax, andmspo gain of function on number of nuclei in DA1muscle. (C) Bar graphs show themean number of nuclei in DA1muscle, inWT, and
in gain-of-function conditions forMp20,Pax, andmspo and asterisks indicate the significance of variation compared to theWT. Values used to plot the graphs are
shown in Table S3. (D–I) Stage 15 embryos stained for Eve (red) and b3-Tub (green). Dorsal portion of three segments in WT, eme-Gal4;UAS-Mp20, eme-Ga-
l4;UAS-Pax, eme-Gal4;UAS-mspo and double gain-of-function contexts eme-Gal4;UAS-Pax;UAS-Mp20 and eme-Gal4;UAS-Mp20;UAS-mspo are shown.
(J–L) Kinetics of fusion in WT and duf-Gal4; UAS-lbe (J) in Pax and Mp20 attenuation (K) and Pax, Mp20, and mspo overexpression (L) contexts. VA2 and DA1
muscles were analyzed in attenuation and overexpresion contexts, respectively. In upper panels, bar graphs show themean number of nuclei, asterisks show the
significance of variation compared with the WT. The values used to plot the graphs are shown in Table S4. In lower panel, only mean values are used to visualize
the number of nuclei according to time AEL.
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Figure 7. Identity Genes Control Muscle-
Specific Fusion Programs by Determining
Combinatorial Code of Expression Levels
of Their Targets
The identity genes eve, lb, and slou are required for
specification of FCs that give rise to DA1, DT1,
SBM, VA2, and VT1muscles. The FC specification
step is completed by stage 12 of embryogenesis
but expression of eve, lb, and slou continues
in later stages. Between, stage 12 and 15, FCs
fuse with a determined number of FCMs to
generate muscles with a specific number of nuclei.
eve, lb, and slou induce the recruitment of 10, 6,
and 3 nuclei, respectively, leading to the DA1,
SBM, and VT1 formation. Slou in combination
with unidentified factors induce two other fusion
programs for DT1 and VA2 muscles. To execute
muscle-specific fusion programs, the identity
genes act via Mp20, Pax, and mspo by establish-
ing a combinatorial code of target’s expressions.
Bold outlines show the target activity in fusion
program.
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Development of metazoan organisms is based on acquisition of
distinct cell identities so that diverse cell types are generated.
During Drosophila myogenesis, muscle cells undergo diversifi-
cation process to form a set of muscles each of which displays
a particular size, shape, and orientation. It has been demon-
strated that the acquisition of muscle identity is initiated by the
identity gene-dependent specification of muscle FCs; however,
how this identity information is translated into specific properties
of resulting muscles remains unknown. Here, to fill this gap, we
analyze roles of identity genes in regulation of myoblast fusion
and identify their targets whose function allow the execution of
muscle-specific programs of fusion.
FCMs Do Not Carry Information about Muscle-Specific
Fusion Programs
Themyoblast fusion is asymmetric and takes place between FCs
and FCMs. Previous reports (Estrada et al., 2006; Beckett and
Baylies, 2007; Beckett et al., 2008) were at the origin of a hypoth-
esis that FCMs are not ‘‘naive’’ myoblasts and contribute to the
modulation of fusion process. In contrast, our results support
a view that FCs rather than FCMs carry the instructive informa-
tion and allow us to conclude that FCMs do not play an active
role in setting the number of fusion events. However, because
the spatial distribution of FCMs seems to be nonuniform (Beckett
and Baylies, 2007), it is conceivable that the local distribution of
FCMs was coordinated with the requirements of FCs to facilitate
fusion process.
Identity Information Transmitted by Identity Genes
to FC Cells Modulates Fusion Programs
The identity genes lb, slou, and eve are required to specify FCs
at the origin of five muscles the DA1, DT1, SBM, VA2, and VT1
(Jagla et al., 1998; Knirr et al., 1999; Su et al., 1999). Here, we
provide evidence that these identity genes are also required for
setting the muscle-specific number of fusions and demonstrate
how this identity information is executed (Figure 7). After specifi-Developcation step, FCs fuse, between the embryonic stage 12 and 15,
with a determined number of FCMs to generate muscles with
a specific number of nuclei. During this time period eve, lb, and
slou continue to be expressed in subsets of developing muscles
and our data show that they are sufficient to establish the
muscle-specific fusion programs in DA1, SBM, and VT1 (11, 7,
and 4 nuclei, respectively). Furthermore, slou in combination
with other factors (see below) contributes to two other programs
that end up with seven to eight fusion events in muscles DT1 and
VA2. To regulate number of fusion events eve, lb, and slou act
by modulating expression of genes involved in dynamics of actin
cytoskeleton or cell adhesion. Starting from stage 13, they
establish a muscle-specific combinatorial code of expression
levels of three targets: Mp20, Pax, and mspo. The combination
of expression of the targets leads to the muscle-specific control
of the number of fusion events. This notion is supported by the
fact that each of identity genes is able to impose at ectopic loca-
tions the combinatorial realisator code of Mp20, Pax, and mspo
expression, and thus, ectopically execute its fusion program
(Figure S6). Given that the code of Mp20, Pax, and mspo is
not sufficient to explain fusion programs in all muscles, we
hypothesize that other identity gene targets exist that modulate
fusion counting.
Moreover, our data are in support of the two-step model of
myoblast fusion according to which a muscle precursor is
formed between stage 12 and 13 by an initial fusion, and then,
between stage 13 and 15, fuses with additional myoblasts until
the muscle reaches its final size (Schroter et al., 2004). The fact
that Mp20, Pax, and mspo are expressed from stage 13
suggests that the transition point between the two steps
depends not only on the timing of FCM migration (Beckett and
Baylies, 2007) but also on the activation of limiting factors such
as the identity gene targets which modulate the number of addi-
tional fusions. As we did not observe nuclear divisions in FCs nor
in growing myotubes in any of the genetic contexts analyzed
(data not shown), we are confident that the number of nuclei
present in each muscle is determined only by the number of
fusion events.mental Cell 19, 317–328, August 17, 2010 ª2010 Elsevier Inc. 325
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Specification of FCs requires combinatorial code of activities of
identity genes (Frasch, 1999). Here, we show that the same iden-
tity genes play instructive roles in subsequent muscle-type-
specific differentiation process. Importantly, our data enlighten
the fact that the identity genes are not equivalent and have
distinct, context-dependent mode of action. eve, lb, and slou
are sufficient to set the fusion programs in DA1, SBM, and VT1
muscles; however, in VA2 and DT1 slou functions in a different
way and seems not to have a decisive role in this process.
Because the specification of the VA2 and DT1 FCs also involves
functions of Poxm, Kr, and ap (Ruiz-Gomez et al., 1997; Duan
et al., 2007), we hypothesize that they act together with slou in
setting fusion programs of VA2 and DT1. This raises an important
question about hierarchy of identity genes during execution of
muscle identity programs and their roles in acquisition of specific
properties of muscles such as number of nuclei, attachment
points, and innervation.
Mp20, Pax, and mspo Act in Execution
of Muscle-Specific Fusion Programs
The data presented here demonstrate that the number of fusion
events in developing muscles is regulated by a muscle-specific
combinatorial realisator code of identity gene targets. In contrast
to the previously identified fusion genes (e.g., Ruiz-Gomez et al.,
2000; Chen and Olson, 2001; Rau et al., 2001) acting in all
muscles, the identified identity targets, Mp20, Pax, and mspo,
display muscle-type specific expression and modulate fusion
in a muscle-type-specific manner proportionally to the level of
their expression. The loss and gain of function of each of them
lead to subtle fusion phenotypes indicating that the range of
fusion events controlled by these three candidates is limited.
Indeed, the loss of function of Mp20 results in loss of two nuclei
in a subset of muscles, whereas its overexpression induces the
recruitment of maximum two FCMs. A similar range of defects
in number of fusion events is observed in Pax and mspo mutant
embryos indicating that they influence fusion process at the
same level.
Mp20 encodes a cytoskeletal protein displaying restricted
expression in adult muscles (Ayme-Southgate et al., 1989) and
sharing sequence homology with the lineage-restricted mouse
proteins SM22alpha, SM22beta, and NP25. These proteins
contain calponin-like repeats, and, in mammals, interact with
F-actin and participate in the organization of the actin cytoskel-
eton (Takahashi and Nadal-Ginard, 1991; Zhang et al., 2002;
Mori et al., 2004; Han et al., 2009). In Drosophila S2R cells, the
RNAi knockdown of Mp20 induces a phenotype of round and
nonadherent cells (Kiger et al., 2003) supporting its role in regu-
lation of fusion process.
The second candidate, Pax (DPxn37), is a scaffold protein that
recruits structural and signaling molecules to the sites of focal
adhesion. Pax has been shown to be involved in the actin
cytoskeleton organization, cell adhesion, cell migration, and
cell survival (Hagel et al., 2002; Deakin and Turner, 2008).
In the developing Drosophila muscles, Pax protein localizes at
muscle-tendon junctions (Yagi et al., 2001; Subramanian et al.,
2003) (Figure S4) suggesting that it may play a role in muscle
attachment. Our analyses of Pax mutant embryos do not reveal
muscle-tendon adhesion defects but show discrete myoblast326 Developmental Cell 19, 317–328, August 17, 2010 ª2010 Elseviefusion phenotypes, which correlate with differential muscle-
specific expression of Pax. The role of Pax in modulating fusion
is consistent with previously described implications of Pax inter-
acting proteins, including ARF6 in myoblast fusion in both
Drosophila and vertebrates, and FAK in vertebrates (Tachibana
et al., 1995; Brown et al., 1996; Chen et al., 2003; Randazzo
et al., 2007; Pajcini et al., 2008; Quach et al., 2009).
Finally, mspo belongs to the F-Spondins, a conserved family
of ECM proteins, which maintain cell-matrix adhesion in multiple
tissues (Feinstein and Klar, 2004). In vertebrates, F-Spondins
have context-dependent effects on axon outgrowth and cell
migration (Schubert et al., 2006). As Mp20, Pax, and Mspo are
expressed in FC cells and growing myotubes, one possibility is
that they modify the spreading and/or motility of FC protrusions
required to attract FCMs. Alternatively, bymodulating actin cyto-
skeleton, Mp20, Pax, and Mspo may also influence the stability
of adhesion between the growing muscle and the FCM creating
permissive conditions or blocking the progression of fusion
process.Muscle Type-Specific Regulation of Fusion Process
by Modulating Fusion Rate
The muscle-type-specific regulation of fusion programs by the
identity genes and their targets raises an intriguing question of
how this regulation is executed from the mechanistic point of
view. Because different levels of expression of Mp20, Pax, and
mspo correlate with different fusion programs in both wild-type
and genetically manipulated embryos, we thought that by
following kinetics of fusion in small and big muscles we may
gain insights into how the fusion programs are modulated. It
turns out that the rate of fusion is proportional to the size of
muscle, meaning the number of fusion events, thus revealing
that the identity genes acting via their targets set up the
frequency of fusion events. Accordingly, loss and gain of func-
tion of identity genes and their targets identified here results in
modulations of fusion programs by accelerating or slowing
down the fusion rate. This finding provides insights into mecha-
nistic understanding of muscle-type-specific regulation of fusion
process and raises an important question about whether this
mechanism is broadly conserved.EXPERIMENTAL PROCEDURES
Fly stocks
All Drosophila melanogaster stocks were grown on standard medium at 25C.
The following strains were used: duf-LacZ (rp298-LacZ; from A. Nose, Univ.
Tokyo, Japan), duf-Gal4 (gift of K. Vijayraghavan, TIFR, India), UAS-lbe (Jagla
et al., 1998), UAS-slou and slouch-Gal4 (from M. Frasch, Univ. Enlargen,
Germany), UAS-duf (Ruiz-Gomez et al., 2000), eme-Gal4 (Han et al., 2002)
and UAS-eve (gift of R. Bodmer, Burnham Institute, USA), mspoc26 and
UAS-mspo (Umemiya et al., 1997), UAS-Pax (from G. C. Chen, Academia
Sinica, Taiwan). Df(2R)Exel7124, P{GawB}5053A, and P{GawB}how24B were
obtained from the BloomingtonDrosophila Stock Center. TheUAS-Mp20RNAi
Ref. 4696R-4, UAS-PaxRNAi Ref. 18061R-2 and UAS-slouRNAi Ref. 6534R-1
lines came from the NIG-Fly collection. DoublemutantsUAS-Mp20RNAi;UAS-
PaxRNAi and UAS-Pax;UAS-Mp20 or UAS-Mp20,UAS-mspo were generated
by standard genetic crosses. All UAS-RNAi lines were crossed with the early
and strong 24B-Gal4 driver to maximize the attenuation effect. Mutants
were balanced using CyO, P{wgen11 LacZ} or TM3, Ser, P{twi-LacZ} and
homozygotes were identified by the absence of LacZ staining. In situ hybrid-
ization or immunochemistry against the transgenes were used to genotyper Inc.
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were performed at 25C.
Generation of UAS-Mp20
The UAS-Mp20 construct was made by subcloning a 555 bp NotI-KpnI
fragment containing the entire Mp20 ORF into the pUAST transformation
vector (Brand and Perrimon, 1993). Primers used for PCR cloning: 50-ATAG
CGGCCGCATGTCTCTTGAGCGTGCCG-30 and 50-GGTACCATATTACTTGC
CGAGCAGGATC-30.
Generation of Paxillin Mutants
Deletions between EY00742 (P{EPgy2}PaxEY00742 BDGP) and EP12861
(DGRC Kyoto #204330) were induced on a stock containing both P elements
in transheterozygote and the transposase Hop6. From the progeny 550 white
males were selected, crossed to w; Bl/CyO females, and then used for a PCR
test for the deletion between the two P elements with the primers AGCG
TTTGGCTAAGATCGCAGTCGTTCTAT and GATTTAATGTTTCTACATTTGGG
ATTTTA. Two deletions were identified and recombined with FRT40A for
induction of mosaic clones.
Rescue Experiments
Genomic fragments for the downstream genes (BAC2), PDLP, and Pax rescue
constructs were subcloned from BACR28G24 (BDGP, ordered from the
Children’s Hospital Oakland Research Institute) and cloned into the transfor-
mation vectors pWR and pWRh (N.H.B., unpublished data). The region of
DNA included in each construct is as follows, with coordinates relative to
base 1 defined as the A of the first Pax ATG. Pax: 960 to 6460 and 9083 to
25821 (deleting three lectin genes within a Pax intron) with GFP inserted
between the last codon and the stop codon (25110/1) with four serines as
a linker; PDLP: 16754 to 24366; and BAC2: 26373 to 37451. Transgenic flies
were generated, and PaxD1/CyO; P{w+, rescue}/+ flies were crossed to each
other. The presence of non-CyO PaxD1/PaxD1 flies were scored for rescue.
To confirm rescue, DNA was extracted and analyzed by PCR to confirm the
presence of the deletion, the absence of the wild-type locus, and the presence
the GFP-tagged Pax gene.
To generate PaxD1 deficient germline clones, males carrying hs-flp; FRT40A
ovoD1/CyO were crossed to PaxD1 FRT40A/CyO females. Larvae from this
cross were heat shocked daily for 1 hr at 37C during 3 days, and the emerging
PaxD1 FRT40A/FRT40A ovoD1 adult females were crossed to PaxD1/CyO,
P{wgen11 LacZ} males.
In Situ Hybridization and Antibody Staining
Fluorescent in situ hybridization with TSA amplification system (Perkin-Elmer)
and immunohistochemistry was done as described previously (Junion et al.,
2007). To generate RNA probes for Mp20 (primers used: 50-ccagcaagcg
caatcccg-30 and 50-GAGGTTCTGGCCAGCCTG-30) and Pax (50-gacgaag
caatccggatgc-30 and 50-CAGCACTCGTCGACAGTGC-30), the corresponding
DNA sequences were cloned by PCR in pGemTeasy. The corresponding anti-
sense RNAs were transcribed in vitro using T7 or SP6 RNA polymerase. For
mspo, Gold collection clone RE52725 was used to generate RNA probe.
For fluorescent staining, the following antibodies were used: guinea pig anti-
Eve (1:1000; from D. Kosman, University of California), mouse anti-Lbe
(1:2500; Jagla et al., 1998), rabbit anti-Slou (1:400; gift of M. Frasch), rabbit
anti-b3-tubulin (1:5000; from R. Renkawitz-Pohl, Philipps Univ., Germany),
rabbit anti-Tm2 (1:50; from J. Sparrow, Univ. York, UK), rabbit anti-MHC
(1:200; from D. Kiehart, Duke University), rabbit anti-LacZ (1:1000; Sigma),
goat anti-GFP (1:300; Biogenesis). Cy3-, Cy5-, and 488-conjugated secondary
antibodies were used (1:300; Jackson Immuno-Research). Embryos were
mounted in Fluoromount-G antifade reagent (Southern Biotech). Labeled
embryos were analyzed using an LSM510 Meta (Zeiss) confocal microscope.
Staging Embryos and Nuclei Counting
In addition to embryonic morphology, the dorsal closure and gut morphology
was used for precise staging all embryos. Staining against the identity genes
were used to determine the number of nuclei in specific muscles: Eve in
DA1, Lbe in SBM, and Slou in DT1, VA2, and VT1 muscles. Nuclei were
counted using 403 objective on a Zeiss LSM510 Meta confocal microscope.
For each muscle/mutant condition analyzed, 30 (Tables S1, S3, and S4) orDevelop40 (Table S1) abdominal hemisegments (A2–A4) at stages 15 were counted
(minimum 10 embryos). For kinetics analyses, 30 hemisegments were counted
at stage 12 (7.20–9.20 hr AEL), 13 (9.20–10.20 hr AEL), 14 (10.20–11.20 hr AEL)
and at early (11.20–12 hr AEL) and late stage 15 (12–13 hr AEL) (Table S4). Data
plots and statistical analyses were performed with Prism 5.0 using Kruskal-
Wallis and Dunn’s post-tests.
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